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The article \[A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men\], written by \[Richard Markus, Vincent Chow, Zhiying Pan and Vladimir Hanes\], was originally published Online First without open access. After publication in volume \[80\], issue \[4\], page \[755--763\] the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) \[2017\] and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (<http://creativecommons.org/licenses/by/4.0/>), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article was corrected.

The original article can be found online at <https://doi.org/10.1007/s00280-017-3416-4>.
